Trace amines such as tyramine, octopamine and β-phenylethylamine bind with high affinity to the mammalian trace amine-associated receptor 1 (Taar1), potentially activating G-proteins in the synaptic membranes of target neurons. Recently there has been significant interest in Taar1, since this receptor can bind certain psychoactive drugs of abuse such as Ecstasy (3,4-methylenedioxymethamphetamine). Surprisingly, Ecstasy has been shown to alter responses of immune cells, and we questioned whether Taar receptors might be responsible for this effect. Using sensitive and quantitative RT-PCR assays, we found no detectable expression of Taar mRNA in bone marrow, or in primary cultures of mouse macrophages and dendritic cells whether quiescent or activated by exposure to lipopolysaccharide or the mouse gamma herpesvirus-68 (γHV-68). Mouse B cells and NK cells isolated from spleen, however, showed expression of several Taar mRNA species. Taar mRNA expression was also upregulated in human peripheral blood lymphocytes following in vitro stimulation with PHA. These studies represent the first to define expression of the mRNAs encoding these trace amine receptors in leukocytes.
Introduction
Trace amines such as tyramine, octopamine and β-phenylethylamine are present at low concentrations in the mammalian central nervous system (Berry, 2004; Branchek and Blackburn, 2003; Burchett and Hicks, 2006; Lindemann and Hoener, 2005; Premont et al., 2001 ) and in peripheral tissues (Zucchi et al., 2006) , and bind with high affinity to Taar1 (Borowsky et al., 2001; Bunzow et al., 2001 ), a member of the trace amineassociated receptor (Taar) family of genes and proteins (Lindemann et al., 2005; Lindemann and Hoener, 2005) . Binding to the receptor is thought to activate G-proteins in the synaptic membranes of target neurons, and when expressed in HEK293 cells, a variety of drugs, including Ecstasy (3,4-methylenedioxymethamphetamine), stimulate the production of cAMP. Ecstasy's EC 50 of 1.7 μM (Bunzow et al., 2001) suggests that the typical micromolar serum levels reached by drug abusers could activate cells expressing the Taar1 protein, providing a mechanism for the direct action of Ecstasy on cells and tissues.
While Ecstasy abuse has been shown to affect immune responses (Connor, 2004) , the exact mechanisms responsible for such effects are not altogether clear. This lack of understanding has limited our ability to define targets of immunomodulation for this drug of abuse. Teenagers and young adults are the age group most likely to abuse Ecstasy (Landry, 2002) , as this drug leads to elevated moods, extroversion, and enhancement of sensual experiences (Downing, 1986; Freese et al., 2002) . Thus the use of Ecstasy at parties and "raves" appears to promote close-contact behaviors between individuals (Freese et al., 2002; Gahlinger, 2004; Ropero-Miller and Goldberger, 1998; Smith et al., 2002) . Such behaviors, by themselves, would appear to increase transmission of a variety of infectious diseases. However if Ecstasy abuse also limits a protective immune response, then such infections might be more numerous or more severe in these Journal of Neuroimmunology 192 (2007) 21 -30 www.elsevier.com/locate/jneuroim
